brain Logo
DE
  • 61

    Nature's biodiversity is the source of our innovation: microorganisms and their enzymes open up unique opportunities for us to develop sustainable and scalable solutions for tomorrow's markets.

    • Company
    • Goals & Values
    • Management
      • Products & Services
      • Enzymes, Microorganisms & Ingredients
      • R&D Services
      • Fermentation Services
      • Sites
      • Production, Blending & Distribution
      • R&D Services
      • Markets
      • Life Science & Pharma
      • Food & Beverages
      • Environmental
    • Pipeline
    • Corporate History
    • Contact
  • 131

    We offer innovative biological solutions and products based on microorganisms and enzymes. These enable industry to improve products, make manufacturing processes more efficient and increase the sustainability of products and processes.

    • Investors
      • BRAIN Biotech AG at a Glance
      • Strategy
      • Key financial figures
      • Segments
    • Why invest
      • Corporate Governance
      • Management & Control
      • Executive Management Board
      • Supervisory Board
      • Declaration on corporate governance
      • Statement of conformity 2024
      • Compensation
      • Articles of Association and Rules of Procedure of the Supervisory Board
      • Financial Publications & Calendar
      • Financial and Corporate News
      • Financial Reports
      • Presentations & Videos
      • Financial Calendar
      • Investor Events
      • Capital Markets Day
      • Glossary
    • Share
      • Annual General Meeting
      • Annual General Meeting 2025
      • Archive
    • FAQ
    • Request Information
  • 163

    We follow established national and international guidelines in our strategy for sustainable corporate development and reporting.

    • Sustainability
    • Our Approach
    • Social Responsibility
    • Environment
    • Corporate Management
    • Download Sustainability Report & ESG Fact Sheet
  • 155
    • News & Media
    • News & Stories
    • Press releases
    • Presentations & Videos
    • Press Contact
  • 171
    • Career
    • Working in the BRAIN Biotech Group
    • Apply for sites
    • Job vacancies in the BRAIN Biotech Group
DE
  • Home
  • News & Media
  • Press releases

Press Releases

03.09.2025
BRAIN Biotech AG appoints Johan Jansén-Storbacka as Executive Vice President of the BRAINBiocatalysts´ enzyme products business
Corporate
Show Article
28.08.2025
BRAIN Biotech reports dynamic Q3 revenue growth in core segment BRAINBiocatalysts
Finance
Show Article
25.08.2025
Corbion and BRAIN Biotech team to shape the future of innovation in nature-based ingredient technologies
Corporate
Show Article
23.07.2025
Experienced biotechnology expert joins the Supervisory Board of BRAIN Biotech AG
Corporate
Show Article
28.05.2025
BRAIN Biotech AG reports final half-year figures for fiscal year 2024/25
Finance
Show Article
20.05.2025
BRAIN Biotech announces buy-out of minorities, new continental European production site, and expansion of its Baking Application Center
Corporate
Show Article
18.03.2025
Results of the 2025 Annual General Meeting for the 2023/24 financial year of BRAIN Biotech AG
Corporate
Show Article
26.02.2025
3M FY 24/25: Starting the year with double digit sales growth in the core BRAINBiocatalysts division
Finance
Show Article
13.02.2025
Biological gold recycling: BRAIN Biotech AG collaborates with PX Group on the PX Urban Mining Initiative
Corporate Technology
Show Article
  • 1
  • 2
  • 3
  • 9
BRAIN Biotech AG

Darmstädter Straße 34 – 36
64673 Zwingenberg
Deutschland

public@brain-biotech.com
Phone: +49 62 51 9331-0
Fax: +49 62 51 9331-11
www.brain-biotech-group.com
Copyright © 2025 BRAIN Biotech AG
Social Networks
Privacy Policy Imprint Contact
Legal aspects Cookie Settings